What kind of investor are you? If you don't know, you might have a problem. It's useful to have a handle on your investment strategy, so that you can better focus on it.
There are many different ways to categorize investing. For example, a Goldilocks-like approach might divide investing strategies into these groups:
Too-aggressive investing: This approach puts your dollars in danger. It can include any of a host of riskier-than-average types of investments, such as options, commodities, currency bets, penny stocks, and even lottery tickets. It's true that some options strategies can be conservative, but many are not, and it's very, very common for options to expire unexercised and worthless.Too-cautious investing: It might seem smart to be very conservative with your money, but if you do that, it might not grow enough to support you in retirement. That's especially true these days, in our environment of ultra-low interest rates. With inflation historically averaging about 3% annually in the U.S., even earning 2% in your bank account or via a bond or CD will leave you losing purchasing power over time.
Just-right investing: For many people, a long-term portfolio mixed with both stocks and bonds is a sound way to grow your net worth.
The bond world features many kinds of bonds, such as government bonds, municipal bonds, and corporate bonds. Government bonds, such as U.S. Treasury bills, bonds, and notes, are the safest, backed by the U.S. government. They pay interest that's taxable on your federal tax return, but is exempt from state and local taxes. Municipal bonds can be riskier, as some local governments are on somewhat shaky ground, but they can therefore offer higher interest rates and their interest is exempt not only from state and local taxes, but also from federal taxes. Corporate bonds are issued by companies that want to raise money. They, too, offer rates higher than government bonds, and their interest is not tax-exempt. In general, the higher their interest rate, the lower their credit rating and healthiness.
Stock investing approaches
A sound stock investment strategy is hard to beat, for long-term growth. Here's a quick rundown of some key approaches. Note that many investors engage in one or more of them -- they're not all mutually exclusive.
Top 5 Quality Stocks To Watch Right Now: Coldwater Creek Inc. (CWTR)
Coldwater Creek Inc., together with its subsidiaries, operates as a multi-channel specialty retailer of women's apparel, accessories, jewelry, and gift items primarily in the United States. It operates premium retail stores located in traditional malls, lifestyle centers, and street locations; merchandise outlet stores; and day spas, which offer spa treatments, including massages, facials, body treatments, manicures, and pedicures, as well as provide relevant apparel and personal care products. The company also offers its products through its e-commerce Web site coldwatercreek.com and catalogs, as well as through phone and mail. As of October 27, 2012, it operated 354 premium retail stores and 38 factory outlet stores, as well as 9 spas. The company was founded in 1984 and is headquartered in Sandpoint, Idaho.
Advisors' Opinion:- [By Roberto Pedone]
Another earnings short-squeeze prospect is specialty retailer of women's apparel, accessories, jewelry and gift items Coldwater Creek (CWTR), which is set to release numbers Tuesday after the market close. Wall Street analysts, on average, expect Coldwater Creek to report revenue of $162.81 million on a loss of 63 cents per share.
The current short interest as a percentage of the float for Coldwater Creek is very high at 18.8%. That means that out of the 12.17 million shares in the tradable float, 3.47 million shares are sold short by the bears. This is a big short interest on a stock with a very low tradable float. If the bulls get the earnings news they're looking for, then this stock could easily explode higher post-earnings.
From a technical perspective, CWTR is currently trending just below its 50-day moving average and well below its 200-day moving average, which is bearish. This stock has been trending sideways for the last two months, with shares moving between $2.16 on the downside and $2.80 on the upside. A high-volume move above the upper-end of its recent range could trigger a breakout trade for CWTR post-earnings.
If you're bullish on CWTR, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $2.51 to $2.69 a share and then once it takes out more resistance at $2.80 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 192,994 shares. If that breakout hits, then CWTR will set up to re-fill some of its previous gap down zone from June that started near $3.60 a share.
I would simply avoid CWTR or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops back below some key near-term support levels at $2.35 to its 52-week low at $2.16 a share with high volume. If we get that move, then CWTR will set up to enter new 52-wee
- [By Eric Volkman]
In turn, it bumps QLogic (NASDAQ: QLGC ) from that index to the S&P SmallCap 600. Finally, QLogic's shift completely displaces Coldwater Creek (NASDAQ: CWTR ) , which will no longer be on the S&P SmallCap 600.
- [By Lauren Pollock]
Coldwater Creek Inc.'s(CWTR) fiscal third-quarter loss widened as the women’s apparel retailer reported a sharp drop in same-store sales and ebbing gross margins. Results missed expectations.
Top 5 Safest Companies To Buy Right Now: Oppenheimer Holdings Inc.(OPY)
Oppenheimer Holdings Inc., through its subsidiaries, operates as a middle-market investment bank and full service broker-dealer. It offers full-service brokerage services covering various investment alternatives, such as exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, and unit investment trusts. The company also provides financial and wealth planning services; margin lending; securities lending; and online equity investing and discount brokerage services. In addition, it offers asset management services for equity, fixed income, large-cap balanced, and alternative investments offered through vehicles, such as privately managed accounts, and retail and institutional separate accounts. Further, the company provides strategic advisory services and capital markets products; institutional equity sales and trading; equity research; equity options and derivatives; convertible bonds; and event driven sales and trading services. Additionally, it trades in non-investment grade public and private debt securities, mortgage-backed securities, sovereign and corporate debt, and distressed securities; provides fixed income research, public finance, and municipal trading services; and is involved in proprietary trading and investment activities. The company also participates in loan syndications and operates as underwriting agent in financing transactions; trades syndicated corporate loans in the secondary market; offers various trust services; and provides mortgage services to developers of commercial properties. It serves high-net-worth individuals and families, corporate executives, small and mid-sized businesses, endowments and foundations, and institutions in the United States, Europe, the Middle East, Asia, and South America. The company was founded in 1977 and is headquartered in New York, New York.
Advisors' Opinion:- [By Hilary Kramer]
With this news, some Wall Street firms finally ��albeit a bit late ��jumped on the ICPT bandwagon.� Citigroup (C) raised its target to $400, stating that its market cap (at the time $5.4 billion) didn�� reach the opportunity for these liver disease treatments.� They estimated that the OCA could exceed a $5 billion sales level.� Oppenheimer (OPY) also raised its target to $360 while Bank of America/Merrill’s (BAC) target is set at $872, the only one not yet exceeded with the most recent move.
Top 5 Safest Companies To Buy Right Now: Johnson Controls Inc.(JCI)
Johnson Controls, Inc. engages in building efficiency, automotive experience, and power solutions businesses worldwide. Its building efficiency business designs, produces, markets, and installs integrated heating, ventilating, and air conditioning systems, as well as building management systems, controls, and security and mechanical equipment. This business also provides technical services, energy management consulting, and operations of real estate portfolios for the non-residential buildings market. In addition, this business offers residential air conditioning and heating systems, and industrial refrigeration products. The company?s automotive experience business designs and manufactures interior products and systems for passenger cars and light trucks, including vans, pick-up trucks, and sport/crossover utility vehicles. It offers seating systems and components; cockpit systems comprising instrument panels and clusters, information displays, and body controllers; overh ead systems, such as headliners and electronic convenience features; floor consoles; and door systems. This business also produces automotive interior systems for original equipment manufacturers. Its power solutions business produces lead-acid automotive batteries serving automotive original equipment manufacturers and the general vehicle battery aftermarket. This business produces lead-acid batteries, as well as offers absorbent glass mat and lithium-ion battery technologies to power hybrid vehicles. The company was formerly known as Johnson Electric Service Company and changed its name to Johnson Controls, Inc. in 1974. Johnson Controls, Inc. was founded in 1885 and is headquartered in Milwaukee, Wisconsin.
Advisors' Opinion:- [By Dan Caplinger]
But the big problem for Magna has come from Europe. Rival Johnson Controls (NYSE: JCI ) , which gets more of its revenue from Europe than from North America, has seen poor conditions in Europe weigh on its overall results. That's consistent with the big problems that major customers Ford (NYSE: F ) and General Motors (NYSE: GM ) have seen in their own European sales figures, with Ford having lost $1.75 billion last year in Europe and expecting that figure to balloon upward to $2 billion for 2013. Although GM managed to reduce its European losses in the first quarter to just $175 million, both it and Ford have a lot of work to do in order to get their operations on the continent back to profitability.
- [By alicet236]
Johnson Controls Inc (JCI): CEO Alex A Molinaroli sold 145,000 Shares
CEO of Johnson Controls Inc (JCI) Alex A Molinaroli sold 145,000 shares on 06/09/2014 at an average price of $50.14. Johnson Controls, Inc. was originally incorporated in the state of Wisconsin in 1885 as Johnson Electric Service Company to manufacture, install and service automatic temperature regulation systems for buildings. Johnson Controls Inc has a market cap of $32.97 billion; its shares were traded at around $49.64 with a P/E ratio of 24.50 and P/S ratio of 0.78. The dividend yield of Johnson Controls Inc stocks is 1.71%. Johnson Controls Inc had an annual average earnings growth of 3.20% over the past 10 years.
- [By Ian Sayson]
The Jakarta Composite Index (JCI) lost 1.9 percent after yesterday�� interest-rate rise fueled speculation current-account data today will show little improvement from the second quarter�� record deficit.
- [By Aimee Duffy]
Johnson Controls (NYSE: JCI ) employs 25,000 people in China, and it was recently one of only 36 companies to be voted a "Top Employer" by the Corporate Research Foundation. Obscure awards aside, the company has a big-time opportunity in China and investors stand to benefit handsomely.�
Top 5 Safest Companies To Buy Right Now: DARA Biosciences Inc.(DARA)
DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. Its products include Soltamox for the treatment of breast cancer; Gemcitabine for first-line therapy for ovarian, breast, lung and pancreatic cancers; and other cancer support therapeutics, as well as generic sterile injectable cytotoxic products. Its drug development programs include KRN5500, a non-narcotic/non-opioid that has completed Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients; and DB959, which has completed a Phase I study for the treatment of metabolic diseases, including type 2 diabetes and dyslipidemia. The company?s pre-clinical drug candidate includes DB900 PPAR gamma/alpha/delta agonists for development in metabolic and inflammatory diseases; DB160, DPPIV enzyme inhibitors with applications in diabetes, stem cell transpl antation, and cancer therapy; and DB200, Carnitine palmitoyltransferase-1 for skin diseases, including psoriasis. DARA BioSciences, Inc. was incorporated in 2002 and is headquartered in Raleigh, North Carolina.
Advisors' Opinion:- [By Bryan Murphy]
Without knowing the whole story, it would be easy to dismiss the big 9% jump from DARA Biosciences Inc. (NASDAQ:DARA) today as nothing more than a little volatility.... bullishness that wasn't destined to linger, especially considering how ugly the market turned in Monday's trading. As is always the case, though, with DARA, there's more to the story. Today's move may well be the official beginning of a much bigger, trade-worthy rally.
No comments:
Post a Comment